swisscann has signed a distribution agreement with a pharmaceutical company that will distribute our medical cannabis products containing Tetrahydrocannabinol (THC) in Europe and the United Kingdom starting from December 2023. We look forward to a long and successful partnership with our new distribution partner.

swisscann team